Sanofi (SNY) Equity Average (2018)
Sanofi (SNY) posted Equity Average of $70.0 billion for Q1 2018.
Sanofi (SNY) Equity Average (2018) Analysis & Trends
Sanofi (SNY) has 1 years of Equity Average data on file, last reported at $70.0 billion in Q1 2018.
- Quarterly Equity Average changed N/A year-over-year to $70.0 billion in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $70.0 billion (changed N/A YoY) and the FY2025 annual result came in at $83.0 billion, up 1.84% from the prior year.
- Equity Average steadied at $70.0 billion in Q1 2018 per SNY's latest filing.
- The five-year high for Equity Average was $70.0 billion in Q1 2018, with the low at $70.0 billion in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 28.87 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 81.37 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -4.96 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 49.27 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 8.92 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 23.11 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 88.29 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 69.97 Bn |